Global EPA And DHA Market Overview
EPA and DHA market accounted for USD 2.3 Billion in 2020 and is estimated to be USD 5.1 Billion by 2030 and is anticipated to register a CAGR of 7.2%.
EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are chain omega-3 polyunsaturated fatty acids that are abundantly found in fatty layers of cold-water fish and shellfish, plant and nut oils, English walnuts, flaxseed, algae oils, and fortified foods. Food and supplement sources of these fatty acids differ in the forms and amounts they contain. This EPA and DHA are important to develop and function optimally in every stage of life. This help reduces inflammation and your risk of chronic diseases, such as heart disease. On its own, DHA supports brain function and eye health.
Global EPA And DHA Market Drivers & Restraints
Continuous demand due to the increasing popularity of EPA/DHA omega-3 as nutritional supplement products which drive the target market growth. The various health benefits provided by EPA and DHA product such as reduce inflammation and risk of chronic diseases, such as heart disease are the major factor drives target market growth. Therefore the rising prevalence of chlorine diseases fuels the market growth. For instance according to fightchronicdisease.org chronic diseases are accountable for seven out of every 10 deaths in the U.S., killing around 1.7 million Americans every year. Additionally, the growing standard of living, with rising health consciousness and rise in disposal income such factor are demanding for nutritious food which led to lifting the growth for the target market. Furthermore, R&D and strong marketing of EPA/DHA products are boosting the market growth. However, some side effects of EPA and DHA supplements are expected to hamper the market growth.
Global EPA And DHA Market Segmentations & Regional Insights
EPA and DHA market is segmented based on by type, by concentration type, by form, by source, by application and region.
By type, the global EPA and DHA market is classified into eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA). By concentration type the global EPA and DHA market is classified into high concentrated, medium concentrated, and low concentrated. Form the global EPA and DHA market is classified into Triglycerides and Ethyl Esters. By source, the global EPA and DHA market is classified into Fish Oil, Algae Oil, Krill Oil, and Other Sources. By application, the global EPA and DHA market is classified into Infant Formulae, Dietary Supplements, Fortified Food and Beverages, Pharmaceuticals, and Other Applications. Dietary supplements are accepted to dominate the market segment owing to rising consumption of such supplement with introducing new such as started consuming capsules for omega-3 and other. Which led to drive the segment growth.
By region, North America is expected to dominate the target market share. Owing to the rising prevalence of chlorine diseases in the region. Additionally, they demand EPA and DHA product due to rising awareness about the benefits of EPA and DHA supplement. Additionally, the high presence of the key player in the market such as Cargill, Nordic Naturals, and Algysis Are the major factor driving the growth for the target market in the region.
EPA and DHA Market, By Type:
- Eicosapentaenoic Acid (EPA)
- Docosahexaenoic Acid (DHA)
EPA and DHA Market, By Concentration Type:
- High Concentrated
- Medium Concentrated
- Low Concentrated
EPA and DHA Market, By Form:
- Triglyceride
- Ethyl Esters
EPA and DHA Market, By Source:
- Fish Oil
- Algae Oil
- Krill Oil
- Other Sources
EPA and DHA Market, By Application:
- Infant Formulae
- Dietary Supplements
- Fortified Food and Beverages
- Pharmaceuticals
- Other Applications
EPA and DHA Market, By Region:
- North America
- Middle East & Africa
- Middle East & Africa EPA and DHA Market, By Type
- Middle East & Africa EPA and DHA Market, By Concentration Type
- Middle East & Africa EPA and DHA Market, By Form
- Middle East & Africa EPA and DHA Market, By Source
- Middle East & Africa EPA and DHA Market, By Application
- Middle East & Africa EPA and DHA Market, By Country
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Latin America EPA and DHA Market, By Type
- Latin America EPA and DHA Market, By Concentration Type
- Latin America EPA and DHA Market, By Form
- Latin America EPA and DHA Market, By Source
- Latin America EPA and DHA Market, By Application
- Latin America EPA and DHA Market, By Country
- Brazil
- Mexico
- Rest of Latin America
- Asia Pacific
- Asia Pacific EPA and DHA Market, By Type
- Asia Pacific EPA and DHA Market, By Concentration Type
- Asia Pacific EPA and DHA Market, By Form
- Asia Pacific EPA and DHA Market, By Source
- Asia Pacific EPA and DHA Market, By Application
- Asia Pacific EPA and DHA Market, By Country
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Europe
- Europe EPA and DHA Market, By Type
- Europe EPA and DHA Market, By Concentration Type
- Europe EPA and DHA Market, By Form
- Europe EPA and DHA Market, By Source
- Europe EPA and DHA Market, By Application
- Europe EPA and DHA Market, By Country
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- North America EPA and DHA Market, By Type
- North America EPA and DHA Market, By Concentration Type
- North America EPA and DHA Market, By Form
- North America EPA and DHA Market, By Source
- North America EPA and DHA Market, By Application
- North America EPA and DHA Market, By Country
- U.S.
- Canada
- Middle East & Africa
Global EPA And DHA Market Competitive Landscape & Key Players
The key players operating the global EPA and DHA market include Koninklijke DSM N.V, KD Pharma Group, Archer Daniels Midland Company, Corbion N.V., Novasep Holding SAS, Neptune Wellness Solutions, BASF SE and Clover Corporation Ltd. The key players are focusing on partnership and mutual understanding strategy. For example on Jul. 2019 DSM, (a global science-based company in Nutrition, Health and Sustainable Living), and Evonik announced the opening of their Veramaris 50-50 joint venture's commercial-scale. This new site has arisen for the commercial production of omega-3 fatty acids rich in EPA and DHA from natural marine algae for sustainable salmon farming.
Global EPA And DHA Market Company Profile
- Koninklijke DSM N.V
- KD Pharma Group
- Archer Daniels Midland Company
- Corbion N.V.
- Novasep Holding SAS
- Neptune Wellness Solutions
- BASF SE
- Clover Corporation Ltd
FAQs
The EPA and DHA market report is segmented into by type, by concentration type, by form, by source, by application and region.
Driving factors include the increasing awareness of omega-3 fatty acids' health benefits, the rising prevalence of chronic diseases, and the growing demand for dietary supplements.
Global restraints may involve concerns about overfishing, the impact of environmental changes on fish populations, and competition from plant-based sources of omega-3 fatty acids.
The report covers North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is estimated to dominate the EPA and DHA Market, experiencing a significantly high revenue share over the forecast period.
The key players operating in the pharmaceutical and nutritional ingredients industry include KD Pharma Group, Archer Daniels Midland Company, Corbion N.V., Novasep Holding SAS, Neptune Wellness Solutions, BASF SE, Clover Corporation Ltd, and Koninklijke DSM N.V.